The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-effectiveness of multi-gene panel sequencing (MGPS) for advanced non-small cell lung cancer (aNSCLC) patients.
 
Lotte Maria Gertruda Steuten
Consulting or Advisory Role - Agendia; Roche Pharma AG (I)
Research Funding - EMD Serono (Inst); Nohla Therapeutics (Inst); Thermo Fisher Scientific
 
Bernardo H. L. Goulart
No Relationships to Disclose
 
Neal J. Meropol
Employment - Flatiron Health
Research Funding - Genomic Health
Patents, Royalties, Other Intellectual Property - US Patent (20020031515): Methods of therapy for cancers characterized by over expression of the HER2 receptor protein; US Patent Office “Systems and methods for matching patients with clinical trials.” (Cui, Mergler, Meropol, Tao, and Guo-Qiang Zhang). Patent pending, filed January 5, 2016. 14/988,132
Travel, Accommodations, Expenses - Flatiron Health
 
Daryl Pritchard
Honoraria - AstraZeneca; Novartis
Travel, Accommodations, Expenses - Novartis
 
Scott David Ramsey
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Kite, a Gilead company; Seagen
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Bristol-Myers Squibb; Flatiron Health